key: cord-1002327-exg97iuh
authors: Tunҫ, Emine M.; Koid Jia Shin, Cassandra; Usoro, Etiowo; Thomas-Smith, Siobhan E.; Trehan, Indi; Migita, Russell T.; Keilman, Ashley E.
title: Croup During the Coronavirus Disease 2019 Omicron Variant Surge
date: 2022-05-10
journal: J Pediatr
DOI: 10.1016/j.jpeds.2022.05.006
sha: 4b4d3cc23279b1a5d0beb6f2c21911ee5610ff70
doc_id: 1002327
cord_uid: exg97iuh

We conducted a retrospective review of medical records of croup patients seen during the COVID-19 pandemic. Approximately 50% underwent testing for SARS-CoV-2. During the Delta wave, 2.8% of those tested were SARS-CoV-2 positive; this increased to 48.2% during the Omicron wave, demonstrating a strong correlation between the Omicron variant and croup.

Croup is a common childhood upper respiratory disease, usually associated with parainfluenza or other endemic viruses, including seasonal coronaviruses. 1 The infection results in varying degrees of inspiratory stridor, hoarse voice, barky cough, and respiratory distress up to and including complete airway obstruction. Sporadic case reports have theorized an association between SARS-CoV-2 and croup. [2] [3] [4] [5] [6] [7] [8] [9] [10] Ex vivo studies have shown that the Omicron variant (B.1.1.529) of SARS-CoV-2 replicates more rapidly in higher airways than previous lineages, suggesting the possibility of an increased risk for croup. 11 As the Omicron variant surged in our community and the number of COVID-19 cases we saw in our practice increased significantly, our clinical observation was that there seemed to be a surge of cases of croup. We therefore conducted this study to compare rates of croup among children in our Emergency Department due to the Delta variant (B.1.617.2), compared with the Omicron variant. We merged regional epidemiologic data with our clinical data to evaluate whether there was indeed a high rate of croup as a manifestation of the Omicron variant.

High-level data wereretrospectively extracted from the electronic medical records of children seen in the Emergency Department (ED) at Seattle Children's Hospital, an academic, quaternarycare hospital with more than 50,000 annual ED visits prior to the COVID-19 pandemic.

Inclusion criteria were patients who were assigned a diagnosis containing the word "croup" testing status and results, disposition (admission) decision, and medications administered (specifically racemic epinephrine). A query was also performed to assess for return visits to the ED within 72 hours as well as for admissions on those repeat visits.

Qualitative SARS-CoV-2 polymerase chain reaction (PCR) testing from nasopharyngeal or midturbinate swabs were obtained at the discretion of the treating clinician, as were interventions including racemic epinephrine and hospitalization. Contemporaneous publicly available local data on the proportion of SARS-CoV-2 samples in surrounding King County, Washington, with spike gene target failure on TaqPath PCR assays was used as a proxy for the proportion of infections caused by the Delta and Omicron SARS-CoV-2 variants. 12 This study was approved by the Seattle Children's Hospital Institutional Review Board.

A total of 401 patients were diagnosed with croup during the Delta surge and 107 patients were diagnosed with croup during the Omicron surge. Patients with croup who presented during the Omicron surge were more likely to test positive for COVID-19 (48.2% vs 2.8%, p < 0.0001, odds ratio 31.8) ( Table I) . The rate of viral respiratory testing remained similar during both time periods. Children with a clinical diagnosis of croup during the Omicron surge were more likely to be administered racemic epinephrine as part of their care (21.5% vs 13.0%, p = 0.032). There J o u r n a l P r e -p r o o f were no differences in presenting age, rate of admission, rate of return to the ED within 72 hours, or admission among those who returned within 72 hours.

Using the local community prevalence of spike gene target failure as a proxy for the Omicron variant, the incidence of croup doubled compared with the rate in prior months, while at the same time the number of cases of parainfluenza virus identified decreased (Figure 1 ).

We have identified a sharp rise in cases of croup seen in our pediatric ED in parallel with the replacement of the SARS-CoV-2 Delta variant by Omicron as the dominant variant in our community. A similar surge was seen by colleagues on the other side of the country, confirming this observation is more than just local to our practice. 13 This increase was not temporally associated with the circulation of parainfluenza virus, and indeed Omicron replaced parainfluenza as the predominant virus associated with croup during this time. Viral testing is not routinely recommended for patients with croup; testing that was performed was for a wide variety of patients and indications, but we do believe our data is a reasonable proxy for local population prevalence. The end of the study period coincided with a decrease in hospital testing capacity and thus we were not able to see if this trend continued with as much precision.

As a pragmatic retrospective data analysis, complete microbiologic data is not available and is a limitation of this study. Testing for respiratory pathogens, including SARS-CoV-2, was up to clinician discretion in the context of active patient care. In order to minimize this bias, we censored data collection in mid-January 2022, the first time that testing supplies became limited.

J o u r n a l P r e -p r o o f 6 With regards to possible sample bias, we note that SARS-CoV-2 testing rates were consistent across the Delta and Omicron waves, at 52.6% and 52.3% of croup patients being tested, respectively.

Croup patients during the Omicron surge were more likely to receive racemic epinephrine, suggesting a more severe initial clinical presentation. Based on admission rates and return visits, there is not enough data to alter current management after ED discharge. 

Role of human coronavirus NL63 in hospitalized children with croup

SARS-CoV-2 and croup, a rare relationship or coincidence?

COVID-19 pandemic impact on respiratory infectious diseases in primary care practice in children

Croup and COVID-19 in a child: A case report and literature review

SARS-CoV-2 and croup, not a rare coincidence

A curious case of croup: Laryngotracheitis caused by COVID-19

A child with sars-cov2-induced croup

Pediatric croup with COVID-19

Laryngotracheobronchitis, croup, an unusual presentation of SARS-CoV-2

Children with croup and SARS-CoV-2 infection during the large outbreak of Omicron

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

COVID-19-associated croup in children

Centers for Disease Control and Prevention. CDC COVID Data Tracker: Variant Proportions

We thank Pavitra Roychoudhury, PhD, Department of Laboratory Medicine